Cooper Co.'s (COO) Unit Gets FDA 510(k) Clearance for Avaira Toric Lenses

The Cooper Companies, Inc. (NYSE: COO) today announced that the U.S. Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira Toric two-week silicone hydrogel contact lenses for astigmatism.

CooperVision will re-launch Avaira Toric with shipments available for select distribution beginning in early May 2012.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Getty Realty discloses separation terms for departing accounting officer
• Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders
• James Hardie sells Fermacell unit to Holcim for €840 million